New agent could be used for certain high-risk groups and may enable longer-term tumor imaging.

Marking its first anniversary, the Koch Institute’s Marble Center for Cancer Nanomedicine goes full steam ahead.

Biologists discover the immune system can eliminate cells with too many or too few chromosomes.

Findings support new strategy of continuous drug delivery by implantable device.

Blocking the transition to a more aggressive state could offer a new treatment strategy.

Senior Tiffany Yeh explores health care and poverty through working abroad, and cultivates her love of music while at home.

Introducing genetic mutations with CRISPR offers a fast and accurate way to simulate the disease.

Hadley Sikes is bridging the gap between engineering and public policy to solve big social problems at home and abroad.

“Synthetic biomarkers” could be used to diagnose ovarian cancer months earlier than now possible.

Koch Institute director advocates support for biomedical research in testimony before the House Committee on Oversight and Government Reform.